Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Blood Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05860595
What this trial is testing

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China 3
Large-scale testing (Phase 3)Looking for participantsNCT07238465
What this trial is testing

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

Who this might be right for
Down SyndromeAutonomic Dysfunction
University of Colorado, Denver 200
Not applicableEnded earlyNCT03590665
What this trial is testing

Blood Flow in Individuals With Down Syndrome

Who this might be right for
Down Syndrome
University of Illinois at Chicago 21
Testing effectiveness (Phase 2)Looking for participantsNCT03587272
What this trial is testing

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Robert Nickel 100
Not applicableStudy completedNCT00000995
What this trial is testing

AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Early research (Phase 1)Study completedNCT00243399
What this trial is testing

Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia

Who this might be right for
Fanconi Anemia
Children's Hospital Medical Center, Cincinnati 10
Early research (Phase 1)Study completedNCT02712346
What this trial is testing

The Role of Endothelin-1 in Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
Augusta University 26
Not applicableStudy completedNCT01284673
What this trial is testing

Characterization of the Cord Blood Stem Cell in Situation of Neonatal Asphyxia

Who this might be right for
Respiratory Distress Syndrome
Assistance Publique Hopitaux De Marseille 10
Testing effectiveness (Phase 2)Study completedNCT05012631
What this trial is testing

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseDiffuse Myocardial Fibrosis
Children's Hospital Medical Center, Cincinnati 14
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490601
What this trial is testing

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Who this might be right for
Fetal HemoglobinBeta-ThalassemiaHemoglobinopathies
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 30
Post-approval studies (Phase 4)WithdrawnNCT00168051
What this trial is testing

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00351156
What this trial is testing

Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease

Who this might be right for
Gaucher Disease
Amicus Therapeutics 50
Early research (Phase 1)Study completedNCT03926819
What this trial is testing

Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT05632354
What this trial is testing

GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Pfizer 47
Not applicableLooking for participantsNCT05629130
What this trial is testing

Embolization in Hereditary Coagulopathies

Who this might be right for
HemophiliaEmbolizationHemarthrosis+3 more
University of Sao Paulo General Hospital 30
Not applicableWithdrawnNCT01374165
What this trial is testing

Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients

Who this might be right for
Sickle Cell Disease
Prolong Pharmaceuticals
Not applicableUnknownNCT03818867
What this trial is testing

Emergency Cerclage in Twin Pregnancies at Imminent Risk of Preterm Birth: an Open-Label Randomised Controlled Trial

Who this might be right for
Preterm BirthTwin Pregnancy With Antenatal ProblemTwin to Twin Transfusion Syndrome
St George's, University of London 31
Next Page